We showed a statistically significant difference between the ADSC and placebo groups in the levels of IL-1 and IL-6 in the peritoneal fluid of the NEC rats, with ADSC injection having the prophylactic potential on the intensity of inflammation. The gene discussed is IL1B; the disease is necrotizing enterocolitis.